The Moody Longevity Trial: Can a Medication for Weight Loss Help You Age Better? A New Research Study at The University of Texas Medical Branch (UTMB) for Adults Ages 55–70

Tirzepatide (Zepbound) is FDA-approved for weight loss—but could it also slow aging and improve your energy, mobility, and brain health? We are enrolling adults 55–70 for a study testing if tirzepatide (Zepbound)—a weight-loss medication—can also slow biological aging. Get compensated. Help us shape the future of healthy aging.

Interested? Contact the UTMB Clinical Research Center at (409) 772-1218.

  Learn more about the Moody Longevity Trial

Thomas Blackwell, MD, FACP and Alan Landay, PhD are the Principal Investigators of this study.